Patent · US Active

Pharmaceutical composition for use in the treatment of a neurodegenerative disease

US9364519B2 · kind B2 · utility

1Cited by

136References

4Claims

0Family size

Assignees

Sanofi-Aventis Deutschland GMBH · DE
University of Ulster · GB

Inventors

Sibylle HESS · Frankfurt am Main, DE
Christian HOELSCHER · Magherafelt, GB
Andrees BOEHME · Paris, FR
Agnes MENUT · Paris, FR
Laurent Pradier · Jouy-le-Moutier, FR
Véronique TAUPIN · Paris, FR

Key dates

Filing date	Sep 4, 2012
Grant date	Jun 14, 2016
Priority date	—
Expiry date	Sep 4, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to a pharmaceutical composition for use in the prevention or/and treatment of a neurodegenerative disease, the composition comprising desPro36Exendin-4(1-39)-Lys6-NH2 or/and a pharmaceutically acceptable salt thereof, and optionally a pharmaceutically acceptable carrier, adjuvant, or/and auxiliary substance. In addition, the present application relates to the use of the pharmaceutical composition for the treatment and prevention of a neurodegenerative disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.